GKIM
AGIO icon

GW&K Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

GW&K Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.1M Buy
1,214,901
+7,600
+0.6% +$215K 0.36% 100
2025
Q4 		$32.9M Buy
1,207,301
+354,359
+42% +$12.4M 0.28% 138
2025
Q3 		$34.2M Sell
852,942
-15,676
-2% -$590K 0.3% 131
2025
Q2 		$28.9M Buy
868,618
+51,092
+6% +$1.55M 0.26% 154
2025
Q1 		$24M Buy
817,526
+134,063
+20% +$4.45M 0.22% 176
2024
Q4 		$22.5M Buy
683,463
+52,517
+8% +$2.47M 0.19% 192
2024
Q3 		$28M Buy
630,946
+35,880
+6% +$1.63M 0.24% 170
2024
Q2 		$25.7M Sell
595,066
-54,319
-8% -$1.96M 0.23% 169
2024
Q1 		$19M Buy
+649,385
New +$17.4M 0.17% 200

Other funds holding AGIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return